Swiss National Bank Neoleukin Therapeutics, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$4.65 - $7.75 $343,635 - $572,725	-73,900 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$9.23 - $13.12 $71,994 - $102,336	7,800 Added 11.8%	73,900 $682,000
Q4 2020 Feb 05, 2021	BUY	$10.17 - $14.56 $62,037 - $88,816	6,100 Added 10.17%	66,100 $932,000
Q2 2020 Aug 05, 2020	BUY	$9.95 - $17.05 $597,000 - $1.02 Million	60,000 New	60,000 $996,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.